Investigator site 0010191 — New York, New York

Investigator site 0010191 is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator site 0010191 has participated in 1 clinical trials.

Therapeutic areas: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Sponsors: argenx.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator site 0010191?

Investigator site 0010191 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator site 0010191 conducted?

Investigator site 0010191 has 1 clinical trials on record. Their work covers Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Is Investigator site 0010191 accredited by Crixeo Health?

Investigator site 0010191 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator site 0010191?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.